In Vitro Activity of Cefotetan against ESBL-Producing Escherichia coli and Klebsiella pneumoniae Bloodstream Isolates from the MERINO Trial

In Vitro Activity of Cefotetan against ESBL-Producing Escherichia coli and Klebsiella pneumoniae Bloodstream Isolates from the MERINO Trial

ABSTRACT Extended-spectrum-beta-lactamase (ESBL)-producing Enterobacterales continue to pose a major threat to human health worldwide. Given the limited therapeutic options available to treat infections caused by these pathogens, identifying additional effective antimicrobials or revisiting existing...

Full description

Bibliographic Details
Main Authors: Adam G. Stewart, Kyra Cottrell, Andrew Henderson, Kanthi Vemuri, Michelle J. Bauer, David L. Paterson, Patrick N. A. Harris
Format: Article
Language:English
Published: American Society for Microbiology 2021-09-01
Series:Microbiology Spectrum
Subjects:
extended-spectrum beta-lactamase
ampC beta-lactamase
antimicrobial susceptibility testing
AmpC
cefotetan
Enterobacterales
Online Access:https://journals.asm.org/doi/10.1128/Spectrum.00226-21

Internet

https://journals.asm.org/doi/10.1128/Spectrum.00226-21

Similar Items